Copyright: ©Author(s) 2026.
World J Gastroenterol. Nov 14, 2026; 32(42): 120476
Published online Nov 14, 2026. doi: 10.3748/wjg.120476
Published online Nov 14, 2026. doi: 10.3748/wjg.120476
Table 4 Summary of the 30-day mortality rates of different risk groups stratified according to the protrusion area-bilirubin-albumin score
| Risk group | Score | n (%) | 30-day mortality (95%CI) | Median survival (months) |
| Low | ≤ 8 | 58 (65) | 8.6% (3.2%-18.1%) | 6.18 (5.03-9.53) |
| Intermediate | 9-10 | 20 (23) | 40.0% (19.1%-63.9%) | 2.12 (0.39-7.52) |
| High | ≥ 11 | 11 (12) | 81.8% (48.2%-97.7%) | 0.33 (0.16-NA) |
- Citation: Ajanakitti W, Bannangkoon K, Tubtawee T, Ina N. Tumor protrusion assessment and clinical integration for enhanced mortality risk prediction in spontaneously ruptured hepatocellular carcinoma. World J Gastroenterol 2026; 32(42): 120476
- URL: https://www.wjgnet.com/1007-9327/full/v32/i42/120476.htm
- DOI: https://dx.doi.org/10.3748/wjg.120476